US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi NVO 2x Daily ETF

18.74

+1.277.28%

Post-market: 18.740.00000.00%16:10 EDT

Volume:119

Turnover:2K

Market Cap:281.11K

PE:- -

High:18.74

Open:17.47

Low:18.74

Close:17.47

52wk High:27.19

52wk Low:17.37

Shares:15.00K

Float Shares:15.00K

Volume Ratio:3.15

T/O Rate:0.79%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Novo Nordisk price target raised to DKK 275 from DKK 250 at JPMorgan

Novo Nordisk call volume above normal and directionally bullish

Novo Nordisk Sales Growth Could Remain Flat This Year

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)

Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk

Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851

Hong Kong Memory Chip Stocks Plunge as Samsung Drops Nearly 8%, Leveraged Product Sinks 16%

South Korea Sees Surge in Seized Illegal Weight-Loss Drugs, Tripling Last Year's Total in Just Six Months

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

South Korea Tightens Single-Stock Leverage Rules, Investors Shift Focus to US ETFs

Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/NVOC/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","market":"US","secType":"STK","nameCN":"Corgi NVO 2x Daily ETF","latestPrice":18.7404,"timestamp":1789675200000,"preClose":17.468,"halted":0,"volume":119,"hourTrading":{"tag":"盘后","latestPrice":18.7404,"preClose":18.7404,"latestTime":"16:10 EDT","volume":4,"amount":74.9616,"timestamp":1789675804314,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.07284176780398449,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"Post-Mkt","change":1.2724,"latestTime":"09-17 16:20:49 EDT","open":17.468,"high":18.7404,"low":18.7404,"amount":2215,"amplitude":0,"askPrice":27.85,"askSize":200,"bidPrice":9.29,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"listingDate":1784001600000,"exchange":"CBOE","adjPreClose":17.468,"nav":18.17,"aum":272550,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":18.7404,"preClose":18.7404,"latestTime":"16:10 EDT","volume":4,"amount":74.9616,"timestamp":1789675804314,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.148151},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":3.148151,"shares":15000,"dividePrice":0,"high":18.7404,"amplitude":0,"preClose":17.468,"low":18.7404,"week52Low":17.37,"pbRate":"--","week52High":27.1863,"institutionHeld":0,"latestPrice":18.7404,"eps":0,"divideRate":0,"volume":119,"delay":0,"ttmEps":0,"open":17.468,"prevYearClose":24.92,"prevWeekClose":18.6239,"prevMonthClose":20.8451,"prevQuarterClose":24.92,"fiveDayClose":19.5606,"twentyDayClose":21.9873},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOC\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662275688","title":"Novo Nordisk price target raised to DKK 275 from DKK 250 at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2662275688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662275688?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:00","pubTimestamp":1787673628,"startTime":"0","endTime":"0","summary":"JPMorgan raised the firm’s price target on Novo Nordisk (NVO) to DKK 275 from DKK 250 and keeps a Neutral rating on the shares. Published first on ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-raised-to-dkk-275-from-dkk-250-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-raised-to-dkk-275-from-dkk-250-at-jpmorgan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","NVOH","NVOX","OZEM","BK4007","NVO","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588","LU0154236417.USD","LU1093756168.USD","PPH","THNR","BK4532","NVOC","BK4585","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756880","title":"Novo Nordisk call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756880","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662756880?lang=en_us&edition=fundamental","pubTime":"2026-08-25 23:50","pubTimestamp":1787673015,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Novo Nordisk (NVO) with 24,990 calls trading, 1.1x expected, and implied vol increasing over 2 points to 34.74%. Oc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOX","IE00BKVL7J92.USD","PPH","BK4585","BK4599","BK4007","LU0154236417.USD","LU1093756325.SGD","THNR","OZEM","BK4588","BK4532","IE00BZ1G4Q59.USD","LU1093756168.USD","NVOC","NVOH","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662732870","title":"Novo Nordisk Sales Growth Could Remain Flat This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2662732870","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662732870?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:33","pubTimestamp":1787661180,"startTime":"0","endTime":"0","summary":"1233 GMT - Novo Nordisk's sales growth could be flat this year, J.P. Morgan says. The Danish drugmaker recently raised its guidance and now forecasts sales growth ranging from flat to minus 6%. The bank raises its 2026 sales forecasts by 5%, largely due to higher forecasts for diabetes and weight-loss drugs Ozempic and Wegovy, partially offset by slowing launch momentum of oral Wegovy in the U.S. Novo Nordisk's top-line could still see modest 1% growth in 2027, JPM says. The bank expects 2% sales growth in 2028, with any further acceleration largely dependent on the successful development of zenagamtide, particularly in the oral format, which could have the highest weight loss of any of the oral drugs. JPM retains its neutral rating for the stock and lifts its price target to 275 Danish kroner from 250 kroner. Shares rise 2.2% to 305.80 kroner.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668974.SGD","IE00BDCRKT87.USD","JPMO","LU1261432733.SGD","LU2236285917.USD","NVOC","LU0976567544.SGD","LU1244550494.USD","BK4534","LU1116320737.USD","BK4566","IE00B3S45H60.SGD","LU0211328371.USD","LU2417539215.USD","LU0683600562.USD","IE00BK4W5L77.USD","LU0820562030.AUD","BK4599","LU0211326839.USD","LU1162221912.USD","LU1551013425.SGD","LU0882574139.USD","IE00BZ1G4Q59.USD","LU0006306889.USD","LU1280957306.USD","LU2242649171.HKD","IE00BHPRN162.USD","BK4516","LU2552382132.HKD","LU0251132253.USD","IE00BN8TJ469.HKD","LU1988902786.USD","LU1914381329.SGD","LU0211326755.USD","SG9999002224.SGD","LU2756315318.SGD","BK4504","LU2505996681.GBP","LU1267930490.SGD","IE00BJTD4V19.USD","IE00BLSP4452.SGD","LU0868494617.USD","LU2211815571.USD","LU0215105999.USD","LU2237443465.HKD","LU0149725797.USD","BK4550","LU1363072403.SGD","LU2264538146.SGD","LU2552382058.USD","BK4207","LU2237443978.SGD","NVOX","LU1894683348.USD","THNR","IE00BDRTCR15.USD","LU0942090050.USD","LU0265550359.USD","LU0211327993.USD","LU0820561818.USD","IE00BFXG1179.USD","LU0048584097.USD","LU0203347892.USD","LU1084165304.USD","LU2023250843.SGD","IE00BYXW3230.USD","LU0971096721.USD","LU0689472784.USD","LU1116320901.HKD","LU1119994496.HKD","LU0345770993.USD","LU0640476718.USD","LU2106854487.HKD","LU2430703251.USD","IE00BKVL7J92.USD","LU0310799852.SGD","LU0345769631.USD","LU0868494708.USD","LU1496350171.SGD","LU0787776722.HKD","IE00BK4W5M84.HKD","LU1366192091.USD","LU0170899867.USD","LU2381873111.SGD","JPO","LU0238689110.USD","IXG","LU2552382215.SGD","LU0256863902.USD","SG9999002232.USD","LU2237443549.SGD","JPM","LU1496350502.SGD","BK4533","LU0859254822.USD","LU2756315664.SGD","PPH","LU2430703178.SGD","IE00B1BXHZ80.USD","XLF","FNCL","LU2244417387.USD","LU2456880835.USD","LU2023250504.SGD","LU1551013342.USD","LU1670628061.USD","LU0154236417.USD","LU2237443895.HKD","IE00BJTD4N35.SGD","IYG","LU1670627923.USD","LU2054465674.USD","LU0208291251.USD","LU1720051108.HKD","BK4581","LU0256863811.USD","LU1548497426.USD","TRUF","LU0106261372.USD","LU2462157665.USD","IE00B1XK9C88.USD","IE0034235295.USD","IE00BJLML261.HKD","LU0417517546.SGD","LU1093756325.SGD","LU1720051017.SGD","LU2430703095.HKD","BK4532","LU0106831901.USD","LU0211331839.USD","IE00B775SV38.USD","LU0320765646.SGD","LU0943347566.SGD","NVO","IE00BKDWB100.SGD","LU1974910355.USD","LU0323591593.USD","LU1668664300.SGD","LU1917777945.USD","LU0265550946.USD","LU2505996509.AUD","LU2023250330.USD","LU2592432038.USD","IE00BLSP4239.USD","IYF","FTXO","BK4585","LU0234572021.USD","LU0496365809.HKD","LU0267386448.USD","LU1244550221.USD","UYG","LU0070302665.USD","IE00BWXC8680.SGD","LU0964807845.USD","LU0345769128.USD","LU1894683264.USD","BK4007","LU2237443622.USD","LU1032466523.USD","LU2213496289.HKD","LU0345770308.USD","LU0320765489.SGD","LU0187121727.USD","TFNS","IE000M9KFDE8.USD","KBWB","BK4588","IE0034235303.USD","IE00BBT3K403.USD","LU1244550577.SGD","LU2357305700.SGD","LU0203345920.USD","OZEM","LU0820561909.HKD","VFH","LU2357627491.SGD","LU1093756168.USD","LU1629891620.HKD","LU2237443382.USD","LU0234570918.USD","LU1064131342.USD","LU1145028129.USD","IE0034235188.USD","NVOH","LU2746668461.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782002","title":"Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662782002?lang=en_us&edition=fundamental","pubTime":"2026-08-25 16:36","pubTimestamp":1787646964,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on Novo Nordisk today and set a price target of DKK290.00. According to TipRanks,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-deutsche-bank-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-deutsche-bank-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1093756168.USD","NVOC","LU0154236417.USD","NVOH","NVOX","OZEM","IE00BKVL7J92.USD","BK4599","PPH","BK4585","LU1093756325.SGD","BK4588","IE00BZ1G4Q59.USD","THNR","BK4532","NVO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662845387","title":"J.P. Morgan Sticks to Its Hold Rating for Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662845387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662845387?lang=en_us&edition=fundamental","pubTime":"2026-08-25 15:25","pubTimestamp":1787642723,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Richard Vosser maintained a Hold rating on Novo Nordisk today and set a price target of DKK275.00. According to TipRanks, Vosse...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-hold-rating-for-novo-nordisk-0qiu-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-hold-rating-for-novo-nordisk-0qiu-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","THNR","BK4588","BK4007","LU1093756168.USD","PPH","BK4585","LU1093756325.SGD","NVO","IE00BKVL7J92.USD","NVOC","OZEM","NVOX","NVOH","BK4532","IE00BZ1G4Q59.USD","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270747","title":"Novo Nordisk’s AMAZE 9 Oral Obesity Trial: A New Pill in the Weight-Loss Race","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270747","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270747?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:31","pubTimestamp":1787589070,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk A/S (NVO) has launched AMAZE 9, a Phase 3 obesity study title...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-amaze-9-oral-obesity-trial-a-new-pill-in-the-weight-loss-race?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisks-amaze-9-oral-obesity-trial-a-new-pill-in-the-weight-loss-race?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVOH","OZEM","BK4588","BK4532","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD","NVOX","PPH","THNR","LU0154236417.USD","NVOC","BK4599","NVO","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270631","title":"Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270631","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270631?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:02","pubTimestamp":1787587320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B dropped 0.5% to DKK299.25 Monday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.3% to 2,710.02.The company closed DKK110.70 below its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 3,241,705, compared to the 50-day average trading volume of 4,317,428.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","NVO","LU1093756325.SGD","NVOH","IE00BZ1G4Q59.USD","BK4585","LU1093756168.USD","NVOX","LU0154236417.USD","IE00BKVL7J92.USD","THNR","BK4532","BK4588","OZEM","BK4007","BK4599","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727717","title":"Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727717","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727717?lang=en_us&edition=fundamental","pubTime":"2026-08-24 23:18","pubTimestamp":1787584692,"startTime":"0","endTime":"0","summary":"Novo Nordisk ( ($NVO) ) has issued an announcement. On 6 May 2026, Novo Nordisk launched a share repurchase programme under EU Safe Harbour rules a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-details-progress-in-dkk-15-billion-share-buyback-programme-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-details-progress-in-dkk-15-billion-share-buyback-programme-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOX","THNR","OZEM","IE00BKVL7J92.USD","BK4585","NVO","NVOH","LU1093756168.USD","LU0154236417.USD","BK4588","NVOC","LU1093756325.SGD","BK4599","BK4007","BK4532","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271595","title":"Lexicon Pharma Earns $10 Million Milestone Payment from Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271595","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271595?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:12","pubTimestamp":1787577120,"startTime":"0","endTime":"0","summary":"Lexicon Pharmaceuticals has earned a third $10 million milestone payment from Novo Nordisk for hitting a key milestone in the clinical development program for its obesity drug.The biopharmaceutical company on Monday said that it has achieved a patient dosing milestone in the continuing phase 1 program for LX9851, a treatment being developed for obesity and associated metabolic disorders.Lexicon and Novo Nordisk signed an exclusive worldwide license agreement for LX9851 last year, under which Novo Nordisk is able to develop, manufacture and commercialize the drug for all indications.So far, Lexicon has earned $75 million of the $1 billion in potential upfront, development, regulatory and commercial milestone payments available under its Novo Nordisk collaboration. Lexicon is also entitled to receive tiered royalties on future LX9851 sales.The development program for LX9851 was kicked off by Novo Nordisk in March to investigate the safety, tolerability, pharmacokinetics and pharmacodynam","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","BK4532","NVOX","LU0154236417.USD","BK4588","LXRX","BK4599","BK4007","THNR","NVO","OZEM","IE00BZ1G4Q59.USD","PPH","BK4585","LU1093756325.SGD","NVOC","LU1093756168.USD","BK4139","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279033","title":"Lexicon earns third $10M milestone payment from Novo Nordisk for LX9851","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279033?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:45","pubTimestamp":1787575521,"startTime":"0","endTime":"0","summary":"Lexicon (LXRX) announced that it has earned a third $10M milestone payment in 2026 from Novo Nordisk (NVO) following the achievement of a patient d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexicon-earns-third-10m-milestone-payment-from-novo-nordisk-for-lx9851-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexicon-earns-third-10m-milestone-payment-from-novo-nordisk-for-lx9851-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOX","NVO","BK4585","PPH","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756168.USD","THNR","IE00BKVL7J92.USD","LU1093756325.SGD","BK4007","NVOH","OZEM","BK4588","BK4532","NVOC","LXRX","BK4139","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194806564","title":"Hong Kong Memory Chip Stocks Plunge as Samsung Drops Nearly 8%, Leveraged Product Sinks 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194806564","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194806564?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:00","pubTimestamp":1787540434,"startTime":"0","endTime":"0","summary":"On August 24, memory chip stocks listed in Hong Kong experienced a broad decline, with the Southern Double Leveraged Samsung Electronics product plummeting 16%. Meanwhile, GigaDevice and VIA...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MUYY","RAMZ","BK4585","RGTZ","UPRO","SPXL","SIMX","VOO","NVOX","RGYY","VRTL","NBIZ","SSNLF","09747","SPY","SPYQ","SPYM","NVOC","OSSL","MULL","SAA","SPXU","RAM","ETNG","DRMP","HIBL","MMAX","BK4543","SPYU","MUG","SPDN","LITC","SPYH","ONTX","SPXS","07747","DRMY","NEBX","KCAI","MUD","COZX","LITU","MVV","MUU","NVOH","VXUS","LITG","IVV","SPUU","07347","NVTX","RGTC","LITZ","RGTX","LABX","MUZ","DISK","EMXC","SDS","BK4007","NBIL","SMAX","BK4170","XW","DRAM","LITX","DMAX","NBIC","TEUP","HBMX","MIC","BK4588","RGTU","DRAL","SH","FTXL","VRC","ALA","NBIG","NVTC","YSPY","SSO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188493561","title":"South Korea Sees Surge in Seized Illegal Weight-Loss Drugs, Tripling Last Year's Total in Just Six Months","url":"https://stock-news.laohu8.com/highlight/detail?id=1188493561","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188493561?lang=en_us&edition=fundamental","pubTime":"2026-08-24 10:04","pubTimestamp":1787537081,"startTime":"0","endTime":"0","summary":"Customs data released on Monday reveals that seizures of illegally imported weight-loss medications such as Wegovy and Mounjaro during the first half of this year have already surpassed the total for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVOC","NVOX","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661729161","title":"Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2661729161","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661729161?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:02","pubTimestamp":1787328120,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 1.6% to DKK300.85 Friday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 1.1% to 2,717.75.The company closed DKK109.10 below its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 3,754,463, compared to the 50-day average trading volume of 4,322,923.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","LU1093756168.USD","IE00BKVL7J92.USD","PPH","LU1093756325.SGD","BK5011","0QIU.UK","BK4585","IE00BZ1G4Q59.USD","NVOX","BK4588","OZEM","BK4599","NVO","LU0154236417.USD","THNR","BK4532","BK4007","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155631742","title":"South Korea Tightens Single-Stock Leverage Rules, Investors Shift Focus to US ETFs","url":"https://stock-news.laohu8.com/highlight/detail?id=1155631742","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155631742?lang=en_us&edition=fundamental","pubTime":"2026-08-05 15:41","pubTimestamp":1785915697,"startTime":"0","endTime":"0","summary":"South Korean investors are rapidly redirecting their capital toward US-listed leveraged exchange-traded funds (ETFs) following the government's stricter regulations on single-stock leveraged ETFs....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","AVL","EO","MGKX","MUZ","AVGX","MIC","AXTX","MULL","QTOC","AVGU","UCC","MUU","MUYY","UMDD","QNTU","AVGW","AVGG","AVS","MUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184959126","title":"Amgen's Strong Second Quarter Drug Sales Drive Upward Forecast Revision and Early-Stage Weight Loss Drug Termination","url":"https://stock-news.laohu8.com/highlight/detail?id=1184959126","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184959126?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:21","pubTimestamp":1785878467,"startTime":"0","endTime":"0","summary":"Amgen reported its second-quarter earnings after the U.S. stock market close on Tuesday, with robust drug sales boosting profits, leading the company to raise its full-year outlook. However, it also...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","MEDI","FHLC","LU0058720904.USD","LU2112291526.USD","LU0289739699.SGD","LU0868494617.USD","CURE","TRUH","XLVI","IBBQ","IE00BJT1NW94.SGD","LU2468319806.SGD","NVOC","PBE","IYH","BK4588","LU0122379950.USD","NBDS","TBXU","IE00B4R5TH58.HKD","THNR","AMGN","IE00B2B36J28.USD","LU0109394709.USD","LU1571399168.USD","FXH","LU1061106388.HKD","IE0002141913.USD","SG9999001440.SGD","LU1057294990.SGD","BK4585","IE00BFTCPJ56.SGD","IBB","BK4533","BIB","BK4599","IE0009355771.USD","LU1023059063.AUD","LU2242646821.SGD","BBH","LU2089984988.USD","LU1983299246.USD","PINK","RSPH","BK4581","LU0889565916.HKD","BK4534","LU2242652126.USD","LU0320765992.SGD","BK4566","PJP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":115,"code":"91000000","status":"200"}]}}